Shire (Vancocin 125 mg and 250 mg capsules) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Shire (Vancocin 125 mg and 250 mg capsules) General Information

Description

Vancocin 125 mg and 250 mg capsules rights. The rights include development of products vancomycin hydrochloride injectable 500 mg, 1 gm and 10 gm and vancomycin hydrochloride oral solution 250 mg and 500 mg.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Lexington, MA
  • United States
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Biotechnology
Acquirer
ANI Pharmaceuticals
Corporate Office
  • Lexington, MA
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Shire (Vancocin 125 mg and 250 mg capsules) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Shire (Vancocin 125 mg and 250 mg capsules)‘s full profile, request access.

Request a free trial

Shire (Vancocin 125 mg and 250 mg capsules) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Shire (Vancocin 125 mg and 250 mg capsules)‘s full profile, request access.

Request a free trial

Shire (Vancocin 125 mg and 250 mg capsules) FAQs

  • Where is Shire (Vancocin 125 mg and 250 mg capsules) headquartered?

    Shire (Vancocin 125 mg and 250 mg capsules) is headquartered in Lexington, MA.

  • What industry is Shire (Vancocin 125 mg and 250 mg capsules) in?

    Shire (Vancocin 125 mg and 250 mg capsules)’s primary industry is Buildings and Property.

  • Is Shire (Vancocin 125 mg and 250 mg capsules) a private or public company?

    Shire (Vancocin 125 mg and 250 mg capsules) is a Private company.

  • What is the current valuation of Shire (Vancocin 125 mg and 250 mg capsules)?

    The current valuation of Shire (Vancocin 125 mg and 250 mg capsules) is .

  • What is Shire (Vancocin 125 mg and 250 mg capsules)’s current revenue?

    The current revenue for Shire (Vancocin 125 mg and 250 mg capsules) is .

  • Who are Shire (Vancocin 125 mg and 250 mg capsules)’s investors?

    Shire has invested in Shire (Vancocin 125 mg and 250 mg capsules).

  • When was Shire (Vancocin 125 mg and 250 mg capsules) acquired?

    Shire (Vancocin 125 mg and 250 mg capsules) was acquired on 01-Aug-2014.

  • Who acquired Shire (Vancocin 125 mg and 250 mg capsules)?

    Shire (Vancocin 125 mg and 250 mg capsules) was acquired by ANI Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »